GROUPAMA ASSET MANAGMENT

Position in ABBV — AbbVie Inc.

CIK 1055969 PARIS, I0

Position in ABBV

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$33,961,063

-$2,550,268 QoQ

Shares Held

156,150

-2.3% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 65.05475504322766.ToString("F0")% Shared 0.ToString("F0")% None 34.945244956772335.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $418,001,230 across 10 Drug Manufacturers - General names. ABBV ranks #4 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	863,629	$170,324,911
2	MRK	Merck & Co., Inc.	874,963	$105,249,299
3	LLY	ELI LILLY & Co	95,376	$87,723,983
4	ABBV	AbbVie Inc. This page	156,150	$33,961,063
5	JNJ	Johnson & Johnson	22,693	$5,547,076
6	GILD	Gilead Sciences, Inc.	37,990	$5,294,666
7	AMGN	Amgen Inc	14,960	$5,263,676
8	PFE	Pfizer Inc	63,889	$1,794,003

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$33,961,063	156,150	-2.3%	Shares	Sole	2026-05-22
2025-12-31	$36,511,331	159,794	-0.5%	Shares	Sole	2026-02-27
2025-09-30	$37,171,663	160,541	+7.3%	Shares	Sole	2025-12-01
2025-06-30	$27,784,900	149,687	+1.6%	Shares	Sole	2025-08-13
2025-03-31	$30,882,619	147,397	+13.3%	Shares	Sole	2025-05-14
2024-12-31	$23,120,013	130,107	-4.2%	Shares	Sole	2025-02-12
2024-09-30	$26,807,712	135,749	+40.3%	Shares	Sole	2024-11-15
2024-06-30	$16,598,848	96,775	+15.3%	Shares	Sole	2024-08-14
2024-03-31	$15,287,841	83,953	-4.1%	Shares	Sole	2024-05-14
2023-12-31	$13,568,088	87,553	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.